BRAVEHEART INVESTMENT GROUP PLC

Share Issue/Capital Change • Mar 18, 2025

National Storage Mechanism | Additional information

RNS Number : 1322B

Braveheart Investment Group plc

18 March 2025

18 March 2025

Braveheart Investment Group plc

(the "Company")

Subscription in IQ-AI Ltd Placing

Braveheart Investment Group plc (AIM: BRH) announces the participation in IQ-AI Ltd's ("IQ-AI") placing to raise £250,000 (the "Placing") via the issuance of 25,000,000 new ordinary shares (the "Placing Shares") at a price of £0.01 per share (the "Issue Price"). The Company, an existing shareholder in IQ-AI, has subscribed for 7,000,000 Placing Shares for a consideration of £70,000. On admission of the Placing Shares, the Company will hold 72,415,862 ordinary shares in IQ-AI which represents 29.35% of the issued share capital of IQ-AI as enlarged by the Placing.

IQ-AI, the parent company of Wisconsin-based Imaging Biometrics, LLC (IB), is focused on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. IQ-AI's ordinary shares are listed on the main market of the London Stock Exchange.

In the year ended 31 December 2023, IQ-AI made a loss before tax of approximately £0.62 million on revenue of approximately £0.6 million and as at that date had net assets of approximately £0.09 million. As at 30 June 2024, IQ-AI had net assets of approximately £0.43 million.

The Board continues to seek investment opportunities, both within its existing portfolio and from outside. The Braveheart Board considers this investment to be a strategic investment and thus an important addition to the Group's portfolio.

For further information:

Braveheart Investment Group plc	Tel: 01738 587555
Trevor Brown, Chief Executive Officer Viv Hallam, Executive Director
Allenby Capital Limited (Nominated Adviser and Joint Broker)	Tel: 020 3328 5656
James Reeve / Ashur Joseph
Peterhouse Capital Limited (Joint Broker)	Tel: 020 7469 0936

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEFLFFIVRITLIE